NCT04785027 Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis Status UNKNOWN Phase PHASE1/PHASE2
NCT04780516 Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04776629 A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors Status COMPLETED Phase PHASE2
NCT04765332 Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients Status COMPLETED Phase N/A
NCT04761627 A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04751396 Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors Status RECRUITING Phase N/A
NCT04750993 Comparison of the Frequency of Subclinic Synovitis in the Distal Interphalangeal Joints of the Hand in Psoriasis Patients Status COMPLETED Phase N/A
NCT04746911 Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) Status COMPLETED Phase PHASE2
NCT04744363 Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) Status COMPLETED Phase PHASE1
NCT04722640 Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity Status UNKNOWN Phase PHASE4
NCT04722094 Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study Status UNKNOWN Phase N/A
NCT04713592 Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement Status COMPLETED Phase PHASE3
NCT04711343 Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04693936 Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis Status ACTIVE_NOT_RECRUITING Phase NA
NCT04680624 Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients Status UNKNOWN Phase NA
NCT04673786 A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT04655313 Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) Status COMPLETED Phase PHASE2